beyond glp 1 Frontiers Obesity and Beyond

Learning Objectives Describe the neurobiological rationale for using GLP-1 receptor agonists in the treatment of alcohol use disorder and other substance use disorders (SUD)

A new sustained-release microsphere formulation of exenatide, known as DA-3091, has shown promise in managing obesity, diabetes, and nonalcoholic fatty liver disease, offering effective metabolic control with less frequent dosing, potentially improving patient compliance

If you put a thin layer on damp, not dry, skin, it will penetrate quickly, Hirsch says

Notable Features: Sermorelin works best when administered before bedtime to matches natural growth hormone release patterns